
LUPKYNIS Strengthens Market Position As Demand For Lupus Nephritis Treatment Grows Delveinsight
(MENAFN- PR Newswire) As a novel calcineurin inhibitor with proven efficacy in improving renal outcomes, LUPKYNIS addresses a high unmet medical need. With increasing awareness, supportive guidelines, and potential global expansion, it is well-positioned …